Funding for this research was provided by:
Michael Smith Foundation for Health Research
Heart and Stroke Foundation of Canada
Heart and Stroke Foundation of British Columbia and Yukon
Vancouver Coastal Health Research Institute
Article History
Accepted: 26 September 2021
First Online: 13 January 2022
Compliance with Ethical Standards
:
: Dr. Field is PI for the SECRET (Study of rivaroxaban for ceREbral venous Thrombosis) trial and receives in-kind study medication from Bayer Canada for the study. She is supported by the Vancouver Coastal Health Research Institute, the Michael Smith Foundation for Health Research, the Heart and Stroke Foundation of Canada. The other authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.